Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/21813
Title: The importance of the smoking factor in personalized complex pharmacotherapy of ischemic heart disease with the use of metabolic correctors
Authors: Zhernakova, N. I.
Romaschenko, O. V.
Snegin, E. A.
Rumbesht, V. V.
Alferov, P. K.
Keywords: medicine
cardiology
smoking
ischemic heart disease
personalized pharmacotherapy
metabolic correctors
trimetazidine
meldonium
phosphocreatine
Issue Date: 2018
Citation: The importance of the smoking factor in personalized complex pharmacotherapy of ischemic heart disease with the use of metabolic correctors / N.I. Zhernakova [и др.] // International Journal of Advanced Biotechnology and Research. - 2018. - Vol.9, N1.-P. 1016-1021.
Abstract: The work is devoted to the study of the significance of the smoking factor in the realization of potentially positive cardiocytoprotective properties of metabolic correctors in the complex therapy of ischemic heart disease (IHD). A randomized study of 160 patients with stable angina pectoris was performed, 60 of them were smoking and 100 of them were non-smoking
URI: http://dspace.bsu.edu.ru/handle/123456789/21813
Appears in Collections:Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)

Files in This Item:
File Description SizeFormat 
Zhernakova_The Importance.pdf284.12 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.